Differential lipid signaling from CD4⁺ and CD8⁺ T cells contributes to type 1 diabetes development.

Autor: White, Tayleur D., Almutairi, Abdulaziz, Ying Gai-Tusing, Stephenson, Daniel J., Stephenson, Benjamin D., Chalfant, Charles E., Xiaoyong Lei, Lu, Brian, Hammock, Bruce D., DiLorenzo, Teresa P., Ramanadham, Sasanka

Publikováno v: Frontiers in Immunology; 2024, p01-14, 14p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Selective Reduction of Ca2+-Independent Phospholipase A2β (iPLA2β)-Derived Lipid Signaling From Macrophages Mitigates Type 1 Diabetes Development.

Autor: Almutairi A; Department of Cell, Developmental, and Integrative Biology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; Comprehensive Diabetes Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; Department of Basic Science, College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia., White TD; Department of Cell, Developmental, and Integrative Biology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; Comprehensive Diabetes Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Stephenson DJ; Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA., Stephenson BD; Program in Cancer Biology, UVA Comprehensive Cancer Center, University of Virginia School of Medicine, Charlottesville, VA., Gai-Tusing Y; Department of Cell, Developmental, and Integrative Biology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; Comprehensive Diabetes Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Goel P; Department of Medicine, Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Phillips DW; Department of Medicine, Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Welner RS; Comprehensive Diabetes Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; Department of Medicine, Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Lei X; Department of Cell, Developmental, and Integrative Biology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; Comprehensive Diabetes Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Hammock BD; Department of Entomology and Nematology, University of California, Davis, Davis, CA., Chalfant CE; Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA.; Program in Cancer Biology, UVA Comprehensive Cancer Center, University of Virginia School of Medicine, Charlottesville, VA.; Research Service, Richmond Veterans Administration Medical Center, Richmond, VA., Ramanadham S; Department of Cell, Developmental, and Integrative Biology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; Comprehensive Diabetes Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.

Publikováno v: Diabetes [Diabetes] 2024 Dec 01; Vol. 73 (12), pp. 2022-2033.